3 most recent filings and news items mentioning NAMS. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/NAMS/news?limit=20"
Pull NAMS filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayNewAmsterdam Pharma reported strong Q2 results including a positive European regulatory opinion for obicetrapib, signaling significant progress for its late-stage CVD pipeline.
View filing at SEC.gov →NewAmsterdam and Menarini received a positive CHMP opinion patent dosing options for obicetrapib, pending further regulatory review.
View filing at SEC.gov →NewAmsterdam Pharma Company N.V. has adopted an Employee Stock Purchase Plan (ESPP) authorizing up to 1,150,000 shares for eligible employees under IRC Section 423. The plan allows the board flexibility to create sub-plans for international employees while maintaining tax-qualifi
View filing at SEC.gov →